IPPro Life Sciences, a fortnightly publication dedicated to the IP implications of biotech, pharma, medical tech and genomics, will be there to report on this complex sector as it develops and heads in new directions, with all of the latest news from around the world.
From private practice life sciences groups, to multinational pharmaceutical companies, university labs and venture capitalists, IPPro Life Sciences has something for everyone with an interest in IP and the life sciences sector.